2020
Sankofa pediatric HIV disclosure intervention did not worsen depression scores in children living with HIV and their caregivers in Ghana
Radcliffe C, Sam A, Matos Q, Antwi S, Amissah K, Alhassan A, Ofori IP, Xu Y, Deng Y, Reynolds NR, Paintsil E. Sankofa pediatric HIV disclosure intervention did not worsen depression scores in children living with HIV and their caregivers in Ghana. BMC Public Health 2020, 20: 1578. PMID: 33081739, PMCID: PMC7576749, DOI: 10.1186/s12889-020-09678-2.Peer-Reviewed Original ResearchConceptsBeck Depression InventoryBDI scoresChildren's Depression InventoryCDI scoresDepression InventoryHIV disclosure interventionsCross-sectional studyHIV statusPresent studyCaregiver-child dyadsLow prevalenceIntervention sitesDepression scoresSignificant associationDisclosure statusConclusionsOur findingsDisclosure interventionCaregiversScoresInterventionChildrenOriginal dyadStatusHIVPrevalence
2019
Reciprocal relationship between depression and Internet gaming disorder in children: A 12-month follow-up of the iCURE study using cross-lagged path analysis
Jeong H, Yim HW, Lee SY, Lee HK, Potenza M, Jo SJ, Son HJ. Reciprocal relationship between depression and Internet gaming disorder in children: A 12-month follow-up of the iCURE study using cross-lagged path analysis. Journal Of Behavioral Addictions 2019, 8: 725-732. PMID: 32359239, PMCID: PMC7044588, DOI: 10.1556/2006.8.2019.74.Peer-Reviewed Original ResearchConceptsLevel of depressionDepressive symptomsDepression InventoryInternet gaming disorderSelf-reported severityChildren's Depression InventorySymptom screenRisk populationsSymptomsSeverityTime pointsCross-lagged path analysisDepressionGaming disorderLongitudinal studyReciprocal relationshipChildrenResearch panelBaselineDisordersAssociationCross-lagged structural equation modelsPrevious studiesLevelsStudy
2008
Menstrual Symptoms in Adolescent Girls: Association with Smoking, Depressive Symptoms, and Anxiety
Dorn L, Negriff S, Huang B, Pabst S, Hillman J, Braverman P, Susman E. Menstrual Symptoms in Adolescent Girls: Association with Smoking, Depressive Symptoms, and Anxiety. Journal Of Adolescent Health 2008, 44: 237-243. PMID: 19237109, PMCID: PMC2667342, DOI: 10.1016/j.jadohealth.2008.07.018.Peer-Reviewed Original ResearchConceptsMenstrual symptomsSmoking statusDepressive symptomsMenstrual Symptom QuestionnaireDepression InventoryEffect of smokingQuality of lifeState-Trait Anxiety InventoryGirls ages 11Children's Depression InventoryGynecological ageMenstrual cycleSymptom questionnaireSmokingSmoking behaviorSymptomsDysmenorrheaMSQ scoresPostmenarcheal girlsAdolescent girlsAnxiety InventorySmokersAge 11Longitudinal analysisAnxietyMeasures matter: the relative contribution of anxiety and depression to suicidal ideation in clinically referred anxious youth using brief versus full length questionnaires
Carter R, Silverman WK, Allen A, Ham L. Measures matter: the relative contribution of anxiety and depression to suicidal ideation in clinically referred anxious youth using brief versus full length questionnaires. Depression And Anxiety 2008, 25: e27-e35. PMID: 18729149, DOI: 10.1002/da.20468.Peer-Reviewed Original ResearchConceptsManifest Anxiety ScaleAnxious youthChildren's Manifest Anxiety ScaleDepression InventoryIndirect effectsChildren's Depression InventoryStructural equation modelingSignificant direct effectSuicidal ideationChildhood anxietyLength versionCross-sectional designAnxiety ScaleFull-length questionnairesBrief versionEquation modelingAnxietyMeasurement strategyIdeationDepressionFull-length versionYouthDifferent findingsRelative contributionRCMAS
2006
Interrater reliability and clinical efficacy of Children's Yale-Brown Obsessive-Compulsive Scale in an outpatient setting
Yucelen A, Rodopman-Arman A, Topcuoglu V, Yazgan M, Fisek G. Interrater reliability and clinical efficacy of Children's Yale-Brown Obsessive-Compulsive Scale in an outpatient setting. Comprehensive Psychiatry 2006, 47: 48-53. PMID: 16324902, DOI: 10.1016/j.comppsych.2005.04.005.Peer-Reviewed Original ResearchConceptsObsessive-compulsive disorderChildren's Yale-Brown ObsessiveCY-BOCS total scoreYale-Brown ObsessiveCY-BOCSChildren's Depression InventoryDepression InventoryClinical efficacyCompulsive ScaleChild Behavior Checklist scoresChild Behavior ChecklistOutpatient settingCY-BOCS scoresImpression ScaleInterrater reliabilityClinical Global Impression scoresTotal scoreChild versionLeyton Obsessional InventoryTurkish versionBehavior ChecklistClinical outpatient settingClinical Global ImpressionCorrelational analysisGlobal Impression Scale
1997
Children's Yale-Brown Obsessive Compulsive Scale: Reliability and Validity
Scahill L, Riddle M, McSwiggin-Hardin M, Ort S, King R, Goodman W, Cicchetti D, Leckman J. Children's Yale-Brown Obsessive Compulsive Scale: Reliability and Validity. Journal Of The American Academy Of Child & Adolescent Psychiatry 1997, 36: 844-852. PMID: 9183141, DOI: 10.1097/00004583-199706000-00023.Peer-Reviewed Original ResearchConceptsChildren's Yale-Brown Obsessive Compulsive ScaleYale-Brown Obsessive Compulsive ScaleObsessive-compulsive disorderObsessive-compulsive symptom severityManifest Anxiety ScaleObsessive-compulsive symptomsObsessive Compulsive ScaleChildren's Manifest Anxiety ScaleCompulsive ScaleCY-BOCS total scoreSymptom severityDepression InventoryChildren's Depression InventoryTotal scoreCY-BOCS scoresAnxiety ScaleConvergent validityValid subscalesInternal consistencyCompulsion scoreAdolescentsSubscalesChildrenInterrater agreementValidity
1996
The Psychological Effects of Parental Human Immunodeficiency Virus Infection on Uninfected Children
Forsyth B, Damour L, Nagler S, Adnopoz J. The Psychological Effects of Parental Human Immunodeficiency Virus Infection on Uninfected Children. JAMA Pediatrics 1996, 150: 1015-1020. PMID: 8859131, DOI: 10.1001/archpedi.1996.02170350017002.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionImmunodeficiency virusDepression InventoryChild Behavior ChecklistUninfected childrenChildren's Depression InventoryVirus infectionBehavior ChecklistImmunodeficiency syndrome (AIDS) clinicPrimary care centersImmunodeficiency syndrome (AIDS) epidemicChildren of mothersSubject childrenChild Behavior Checklist scoresManifest Anxiety ScaleRevised Children's Manifest Anxiety ScaleAnxiety ScaleMaternal maritalChildren's Manifest Anxiety ScaleSame hospitalCare centerSymptomatic mothersAsymptomatic mother
1993
Fluoxetine and Methylphenidate in Combination for Treatment of Attention Deficit Disorder and Comorbid Depressive Disorder
GAMMON G, BROWN T. Fluoxetine and Methylphenidate in Combination for Treatment of Attention Deficit Disorder and Comorbid Depressive Disorder. Journal Of Child And Adolescent Psychopharmacology 1993, 3: 1-10. PMID: 19630593, DOI: 10.1089/cap.1993.3.1.Peer-Reviewed Original ResearchConners' Parent Rating ScaleGlobal Assessment ScaleChildren's Depression InventoryAttention deficit disorderTherapeutic responseDepression InventoryInadequate therapeutic responseChildren's Global Assessment ScaleDoses of fluoxetineWeeks of treatmentDeficit disorderPositive therapeutic responseSignificant side effectsSubstantial clinical effectsComorbid depressive disorderAddition of fluoxetineAttention deficit hyperactivity disorderFluoxetine dosageClinical effectsClinical statusOpen trialDepressive disorderSide effectsParent Rating ScaleAssessment Scale
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply